InsidersTradesSigma
Track the MONTE ROSA THERAPEUTICS INC share price and the full insider trade history of the company, a listed issuer based in United States. Shares are quoted on the US market, under the oversight of SEC (Form 4). Market capitalisation: €1.1bn. The latest transaction was filed on 29 June 2026 (Notice of proposed sale (Form 144)). Among the most active insiders: FILIP JANKU. The full history is openly available.
Analysts rate MONTE ROSA THERAPEUTICS INC Strong Buy (bullish), based on 6 analysts. Average price target: US$28.50.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
3 of 3 declarations
MONTE ROSA THERAPEUTICS INC 是一家生物技术公司，专注于开发针对癌症和其他严重疾病的创新疗法。